0000899243-16-011555.txt : 20160112 0000899243-16-011555.hdr.sgml : 20160112 20160112160711 ACCESSION NUMBER: 0000899243-16-011555 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160108 FILED AS OF DATE: 20160112 DATE AS OF CHANGE: 20160112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashburn Theodore CENTRAL INDEX KEY: 0001627978 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 161338875 MAIL ADDRESS: STREET 1: 1688 WASHINGTON STREET #1 CITY: BOSTON STATE: MA ZIP: 02118 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-08 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001627978 Ashburn Theodore C/O DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 0 1 0 0 See Remarks Employee Stock Option (Right to Buy) 9.09 2016-01-08 4 A 0 75000 0.00 D 2026-01-08 Common Stock 75000 75000 D The option vests in 48 monthly installments over the four-year period with a vesting start date of January 8, 2016, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date. Senior Vice President, Product Strategy and Operations /s/ Michael Todisco, attorney-in-fact 2016-01-12